Day: February 16, 2022

VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) — COVER TECHNOLOGIES INC. (CSE: COVE) (OTC: MGPRF) (Frankfurt: 304A) (the “Company” or “Cover”) is pleased to announce that it has closed a non-brokered private placement and issued 1,453,431 common shares (“Shares”) at a price of CAD $0.255 per Share for gross aggregate proceeds of $370,624.91 (the “Private Placement”). No finder’s fees were paid on the Private Placement. The Company intends to use the net proceeds from the Private Placement for payment of current payables and general working capital purposes. All securities issued in connection with the Private Placement are subject to a statutory hold period of four months and one day from the date of issuance. On behalf of the Board of Directors of the Company, COVER TECHNOLOGIES INC. “Dorian Banks” Dorian...

NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced the outcome of the U.S. Food and Drug Administration (“FDA”) joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee on IV tramadol. In the final part of the public meeting, the Advisory Committee voted yes or no on the following question: “Has the Applicant submitted adequate information to support the position that the benefits of their product outweigh the risks for the management of acute pain severe enough to require an opioid analgesic in an inpatient setting?” The results are 8 yes votes and 14 no votes. FDA Advisory Committees provide the FDA...

Progress in the zoning process on several strategic projects, together with improved market conditions, contributed to $580.7 million in incremental property values, which in turn led to net income and comprehensive income for Q4 2021 increasing by $603.7 million as compared to the same period in 2020, representing an increase of $3.46 per Unit; FFO per Unit for Q4 2021 increased by $0.06 or 12.0% as compared to the same period in 2020; Continued advancement of non-retail pipeline of 283 projects representing approximately 59 million square feet across the network (41 million square feet at the Trust’s share); and Portfolio continues to provide recurring income with an in-place occupancy rate of 97.4% and committed occupancy rate of 97.6%.TORONTO, Feb. 15, 2022 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres”,...

MALVERN, Pa., Feb. 15, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that the Company’s Board of Directors has approved a 1-for-35 reverse stock split of its common shares (the “Reverse Stock Split”). The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on February 16, 2022 and the Company’s common stock will open for trading on The Nasdaq Capital Market on a post-split basis under the Company’s existing trading symbol “BXRX”. At such time, the Company’s common stock will also commence trading under a new CUPSIP number, 07160F206. Baudax Bio expects that the Reverse Stock Split, which was approved by shareholders at a special shareholder meeting on February 9, 2022 will increase...

SINGAPORE, Feb. 16, 2022 (GLOBE NEWSWIRE) —  PubMatic (Nasdaq: PUBM), a sell-side platform that delivers superior outcomes for digital advertising, today released the findings from a custom commissioned Forrester Consulting study entitled “The State Of Programmatic In-App Advertising In APAC.” The study, which surveyed 472 advertising decision makers in China, Singapore, India, Japan, Indonesia, South Korea, Thailand and Vietnam, uncovers several significant findings. As advertising budgets in APAC shift towards digital media, mobile in-app has emerged as the preferred digital channel, securing the highest percentage of budget allocation over the next 12 months – 20% vs. 17% for mobile web, 16% for connected TV (CTV) and 15% for desktop. Within this channel, buyers are increasingly embracing programmatic as a critical part of media...

NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) — Talkspace (Nasdaq: TALK), a leading virtual behavioral healthcare company, today announced that Doug Braunstein, Chairman of the Board and Interim Chief Executive Officer, and Jennifer Fulk, Chief Financial Officer, will participate in Citi’s 2022 Virtual Healthcare Conference, including a fireside chat presentation on Wednesday, February 23, 2022, at 3:30 p.m. ET. The audio webcast and related materials will be available online at https://investors.talkspace.com/. About Talkspace Talkspace is a leading virtual behavioral healthcare company enabled by a purpose-built technology platform. As a digital healthcare company, all care is delivered through an easy-to-use and fully encrypted web and mobile platform, consistent with HIPAA and other state regulatory requirements. Today, the need...

U.S. Presidential Review Ends Following ITC’s Finding of Violation By DuPont Aurora, IL, Feb. 15, 2022 (GLOBE NEWSWIRE) — CMC Materials, Inc. (Nasdaq: CCMP) (“CMC”), a leading global supplier of consumable materials primarily to semiconductor manufacturers, today announced the conclusion of United States Presidential review, thereby affirming the Company’s favorable Final Determination in its International Trade Commission (“ITC”) case against DuPont de Nemours, Inc. and several DuPont subsidiaries (collectively, “DuPont”).  As announced in December, the ITC found DuPont is unlawfully importing, selling, and marketing in the United States certain chemical mechanical planarization (“CMP”) slurries and components thereof that infringe a patent owned by CMC that is fundamental to advanced dielectric CMP slurries.  In that ruling,...